These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30293764)

  • 1. Mitigating bias in observational vaccine effectiveness studies using simulated comparator populations: Application to rotavirus vaccination in the UK.
    Hungerford D; Vivancos R; Read JM; Bonnett LJ; Bar-Zeev N; Iturriza-Gómara M; Cunliffe NA; French N
    Vaccine; 2018 Oct; 36(45):6674-6682. PubMed ID: 30293764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population effectiveness of the pentavalent and monovalent rotavirus vaccines: a systematic review and meta-analysis of observational studies.
    Hungerford D; Smith K; Tucker A; Iturriza-Gómara M; Vivancos R; McLeonard C; A Cunliffe N; French N
    BMC Infect Dis; 2017 Aug; 17(1):569. PubMed ID: 28810833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of vaccination with the pentavalent rotavirus vaccine in Nicaragua as determined using the screening method.
    Cardellino A; Khawaja S; Sánchez Cruz E; Mast TC
    Hum Vaccin Immunother; 2013 Jul; 9(7):1449-53. PubMed ID: 23571175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of self-financed rotavirus vaccines on acute gastroenteritis primary care episodes using real-world data in Spain: a propensity score-matched analysis of cohort study.
    López-Lacort M; Muñoz-Quiles C; Díez-Domingo J; Orrico-Sánchez A
    Eur J Pediatr; 2024 Jul; 183(7):2843-2853. PubMed ID: 38584228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States.
    Wang FT; Mast TC; Glass RJ; Loughlin J; Seeger JD
    Pediatrics; 2010 Feb; 125(2):e208-13. PubMed ID: 20100757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-World Effectiveness of Pentavalent Rotavirus Vaccine Among Bedouin and Jewish Children in Southern Israel.
    Leshem E; Givon-Lavi N; Tate JE; Greenberg D; Parashar UD; Dagan R
    Clin Infect Dis; 2016 May; 62 Suppl 2():S155-60. PubMed ID: 27059350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of rotavirus pentavalent vaccine under a universal immunization programme in Israel, 2011-2015: a case-control study.
    Muhsen K; Anis E; Rubinstein U; Kassem E; Goren S; Shulman LM; Ephros M; Cohen D
    Clin Microbiol Infect; 2018 Jan; 24(1):53-59. PubMed ID: 28442435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ecological assessment of the direct and indirect effects of routine rotavirus vaccination in Merseyside, UK using data from multiple health systems: a study protocol.
    Hungerford D; Vivancos R; French N; Iturriza-Gomara M; Cunliffe N
    BMJ Open; 2014 Nov; 4(11):e006161. PubMed ID: 25424995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa.
    Tapia MD; Armah G; Breiman RF; Dallas MJ; Lewis KD; Sow SO; Rivers SB; Levine MM; Laserson KF; Feikin DR; Victor JC; Ciarlet M; Neuzil KM; Steele AD
    Vaccine; 2012 Apr; 30 Suppl 1():A79-85. PubMed ID: 22520141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling the epidemiological impact of rotavirus vaccination in Germany--a Bayesian approach.
    Weidemann F; Dehnert M; Koch J; Wichmann O; Höhle M
    Vaccine; 2014 Sep; 32(40):5250-7. PubMed ID: 25045820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of nonspecific protection against all-cause nonrotavirus gastroenteritis by vaccination with orally administered rotavirus vaccine.
    Grant L; Watt J; Moulton L; Weatherholtz R; Reid R; Santosham M; O'Brien K
    J Pediatr Gastroenterol Nutr; 2013 Jun; 56(6):635-40. PubMed ID: 23343932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the state immunization information system to assess rotavirus vaccine effectiveness in Connecticut, 2006-2008.
    Guh AY; Hadler JL
    Vaccine; 2011 Aug; 29(37):6155-8. PubMed ID: 21723356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding Variation in Rotavirus Vaccine Effectiveness Estimates in the United States: The Role of Rotavirus Activity and Diagnostic Misclassification.
    Amin AB; Lash TL; Tate JE; Waller LA; Wikswo ME; Parashar UD; Stewart LS; Chappell JD; Halasa NB; Williams JV; Michaels MG; Hickey RW; Klein EJ; Englund JA; Weinberg GA; Szilagyi PG; Staat MA; McNeal MM; Boom JA; Sahni LC; Selvarangan R; Harrison CJ; Moffatt ME; Schuster JE; Pahud BA; Weddle GM; Azimi PH; Johnston SH; Payne DC; Bowen MD; Lopman BA
    Epidemiology; 2022 Sep; 33(5):660-668. PubMed ID: 35583516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A population based study comparing changes in rotavirus burden on the Island of Ireland between a highly vaccinated population and an unvaccinated population.
    Armstrong G; Gallagher N; Cabrey P; Graham AM; McKeown PJ; Jackson S; Dallat M; Smithson RD
    Vaccine; 2016 Sep; 34(39):4718-4723. PubMed ID: 27527819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epidemiology of all-cause and rotavirus acute gastroenteritis and the characteristics of rotavirus circulating strains before and after rotavirus vaccine introduction in Yemen: analysis of hospital-based surveillance data.
    Banajeh SM; Abu-Asba BA
    BMC Infect Dis; 2015 Oct; 15():418. PubMed ID: 26464210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Patients With Diarrhea Who Test Negative for Rotavirus as Controls to Estimate Rotavirus Vaccine Effectiveness Through Case-Control Studies.
    Tate JE; Patel MM; Cortese MM; Payne DC; Lopman BA; Yen C; Parashar UD
    Clin Infect Dis; 2016 May; 62 Suppl 2():S106-14. PubMed ID: 27059343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine.
    Breiman RF; Zaman K; Armah G; Sow SO; Anh DD; Victor JC; Hille D; Ciarlet M; Neuzil KM
    Vaccine; 2012 Apr; 30 Suppl 1():A24-9. PubMed ID: 22520132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of self-financed rotavirus vaccination in Ise City, Japan.
    Ito M; Higashigawa M
    Hum Vaccin Immunother; 2021 Dec; 17(12):5650-5655. PubMed ID: 34641737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between mixed rotavirus vaccination types of infants and rotavirus acute gastroenteritis.
    Mohammed A; Immergluck L; Parker TC; Jain S; Leong T; Anderson EJ; Jerris RC
    Vaccine; 2015 Oct; 33(42):5670-5677. PubMed ID: 26322843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of monovalent rotavirus vaccine in a high-income, predominant-use setting.
    Doll MK; Buckeridge DL; Morrison KT; Gagneur A; Tapiero B; Charest H; Quach C
    Vaccine; 2015 Dec; 33(51):7307-7314. PubMed ID: 26546262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.